Cargando…

Ductal carcinoma in situ: to treat or not to treat, that is the question

Ductal carcinoma in situ (DCIS) now represents 20–25% of all ‘breast cancers’ consequent upon detection by population-based breast cancer screening programmes. Currently, all DCIS lesions are treated, and treatment comprises either mastectomy or breast-conserving surgery supplemented with radiothera...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Seijen, Maartje, Lips, Esther H., Thompson, Alastair M., Nik-Zainal, Serena, Futreal, Andrew, Hwang, E. Shelley, Verschuur, Ellen, Lane, Joanna, Jonkers, Jos, Rea, Daniel W., Wesseling, Jelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6697179/ https://www.ncbi.nlm.nih.gov/pubmed/31285590 http://dx.doi.org/10.1038/s41416-019-0478-6

Ejemplares similares

Variability in grading of ductal carcinoma in situ among an international group of pathologists
por: van Seijen, Maartje, et al.
Publicado: (2021)

Long-term risk of subsequent ipsilateral lesions after surgery with or without radiotherapy for ductal carcinoma in situ of the breast
por: van Seijen, Maartje, et al.
Publicado: (2021)

Contralateral breast cancer risk in patients with ductal carcinoma in situ and invasive breast cancer
por: Giardiello, Daniele, et al.
Publicado: (2020)

Prediction Models and Decision Aids for Women with Ductal Carcinoma In Situ: A Systematic Literature Review
por: Schmitz, Renée S. J. M., et al.
Publicado: (2022)

Cause-specific Mortality in a Population-based Cohort of 9799 Women Treated for Ductal Carcinoma In Situ
por: Elshof, Lotte E., et al.
Publicado: (2018)

MIND the translational gap: Preclinical models of ductal carcinoma in situ
por: Hutten, Stefan J., et al.
Publicado: (2023)

A living biobank of patient-derived ductal carcinoma in situ mouse-intraductal xenografts identifies risk factors for invasive progression
por: Hutten, Stefan J., et al.
Publicado: (2023)

The impact of patient characteristics and lifestyle factors on the risk of an ipsilateral event after a primary DCIS: A systematic review
por: Alaeikhanehshir, Sena, et al.
Publicado: (2020)

Mouse intraductal modeling of primary ductal carcinoma in situ
por: Hutten, Stefan J., et al.
Publicado: (2023)

Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer
por: Lips, Esther H., et al.
Publicado: (2022)

Pathologic response of ductal carcinoma in situ to neoadjuvant systemic treatment in HER2-positive breast cancer
por: Groen, Emma J., et al.
Publicado: (2021)

Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort study
por: Schmitz, Renée S J M, et al.
Publicado: (2023)

Comprehensive multiplexed immune profiling of the ductal carcinoma in situ immune microenvironment regarding subsequent ipsilateral invasive breast cancer risk
por: Almekinders, Mathilde M., et al.
Publicado: (2022)

Pathological and Biological Differences Between Screen-Detected and Interval Ductal Carcinoma in situ of the Breast
por: de Roos, Marnix A., et al.
Publicado: (2007)

Reliability of preoperative breast biopsies showing ductal carcinoma in situ and implications for non-operative treatment: a cohort study
por: Mannu, Gurdeep S., et al.
Publicado: (2019)

Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situ
por: Almekinders, Mathilde M. M., et al.
Publicado: (2021)

To treat or not to treat, that is the question(*)
por: Sorscher, Steven
Publicado: (2020)

Treatment results in patients with ductal carcinoma in situ treated with adjuvant radiotherapy
por: GÜZELÖZ, Zeliha, et al.
Publicado: (2019)

7. To treat or not to treat, that is the question
por: Malpas, Alice, et al.
Publicado: (2017)

Treatment outcome of ductal carcinoma in situ patients treated with postoperative radiation therapy
por: Lim, Yu Jin, et al.
Publicado: (2014)

Association of Radiotherapy With Survival in Women Treated for Ductal Carcinoma In Situ With Lumpectomy or Mastectomy
por: Giannakeas, Vasily, et al.
Publicado: (2018)

The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study
por: Elshof, Lotte E., et al.
Publicado: (2017)

Status of Intraductal Therapy for Ductal Carcinoma in Situ
por: Flanagan, Meghan, et al.
Publicado: (2010)

Comprehensive characterization of pre- and post-treatment samples of breast cancer reveal potential mechanisms of chemotherapy resistance
por: Hoogstraat, Marlous, et al.
Publicado: (2022)

Clinical Outcomes of Ductal Carcinoma In Situ of the Breast Treated with Partial Mastectomy without Adjuvant Radiotherapy
por: Hwang, Seung Hyun, et al.
Publicado: (2012)

Trends in Axillary Surgery for Treating Ductal Carcinoma In Situ: A Korean Population-based Study
por: Shin, Young Duck, et al.
Publicado: (2021)

Renal replacement therapy: to treat, or not to treat, that is the question...
por: Joannidis, Michael, et al.
Publicado: (2013)

653. To Treat or Not to Treat Corynebacterium striatum? That is the Question
por: Soriano, Katrina, et al.
Publicado: (2018)

Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting
por: Habel, Laurel A, et al.
Publicado: (2009)

Clinicopathological predictive factors for ipsilateral and contralateral events following initial surgery to treat ductal carcinoma in situ
por: Tamura, Nobuko, et al.
Publicado: (2015)

Trends and clinicopathological predictors of axillary evaluation in ductal carcinoma in situ patients treated with breast‐conserving therapy
por: Huang, Nai‐si, et al.
Publicado: (2017)

To treat or not to treat Alzheimer’s disease by the ketogenic diet? That is the question
por: Ułamek-Kozioł, Marzena, et al.
Publicado: (2019)

Intention-to-treat. What is the question?
por: Feinman, Richard D
Publicado: (2009)

Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women
por: Elshof, Lotte E., et al.
Publicado: (2016)

De-novo acute myeloid leukemia in a BRCA positive female with locally treated ductal carcinoma In Situ
por: Nabrinsky, Edward, et al.
Publicado: (2021)

Pure Ductal Carcinoma In Situ of the Breast: Analysis of 270 Consecutive Patients Treated in a 9-Year Period
por: Chiappa, Corrado, et al.
Publicado: (2021)

The Feasibility of Omitting Postoperative Radiotherapy in Japanese Patients With Ductal Carcinoma In Situ of Breast Treated With Breast-Conserving Surgery
por: Nakashima, Akihiro, et al.
Publicado: (2023)

Evaluation of the EGFR polymorphism R497K in two cohorts of neoadjuvantly treated breast cancer patients
por: Sobral-Leite, Marcelo, et al.
Publicado: (2017)

Ductal carcinoma in situ (DCIS)
por: Holland, R
Publicado: (2002)

Ductal Carcinoma In Situ of the Breast
por: Lee, Richard J., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_vg84g9hpnfuorjrhtjpe8k7ks9